Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy
Year: 1997
Type: article
Source: Rheumatology
Authors: F. M. Brennan, K. A. Browne, P. A. Green, J. M. Jaspar, R. N. Maini, M. Feldmann
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2111959500
